These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23786546)

  • 1. Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
    Seidel G; Werner C; Weger M; Steinbrugger I; Haas A
    Acta Ophthalmol; 2013 Sep; 91(6):e482-5. PubMed ID: 23786546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Iida T; Kano M
    Am J Ophthalmol; 2012 Mar; 153(3):504-514.e1. PubMed ID: 22078902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
    Spielberg L; Leys A
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results.
    Larsen M; Schmidt-Erfurth U; Lanzetta P; Wolf S; Simader C; Tokaji E; Pilz S; Weisberger A;
    Ophthalmology; 2012 May; 119(5):992-1000. PubMed ID: 22424834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
    Introini U; Torres Gimeno A; Scotti F; Setaccioli M; Giatsidis S; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
    Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
    Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study.
    Kaiser PK; Boyer DS; Cruess AF; Slakter JS; Pilz S; Weisberger A;
    Ophthalmology; 2012 May; 119(5):1001-10. PubMed ID: 22444829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Ranibizumab monotherapy versus combination of Ranibizumab with photodynamic therapy with neovascular age-related macular degeneration.
    Krebs I; Vécsei Marlovits V; Bodenstorfer J; Glittenberg C; Ansari Shahrezaei S; Ristl R; Binder S
    Acta Ophthalmol; 2013 May; 91(3):e178-83. PubMed ID: 23241227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.
    Sivaprasad S; Patra S; DaCosta J; Adewoyin T; Shona O; Pearce E; Chong NV
    Ophthalmologica; 2011; 225(4):200-6. PubMed ID: 21293163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranibizumab in retinal angiomatous proliferation (RAP): influence of RAP stage on visual outcome.
    Reche-Frutos J; Calvo-Gonzalez C; Pérez-Trigo S; Fernandez-Perez C; Donate-Lopez J; Garcia-Feijoo J
    Eur J Ophthalmol; 2011; 21(6):783-8. PubMed ID: 21484755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year results of combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Iida T; Kano M; Itagaki K
    Jpn J Ophthalmol; 2016 Jan; 60(1):42-50. PubMed ID: 26498642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subfoveal choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.
    Maruko I; Iida T; Oyamada H; Sugano Y; Saito M; Sekiryu T
    Retina; 2015 Apr; 35(4):648-54. PubMed ID: 25627088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation.
    Lo Giudice G; Gismondi M; De Belvis V; Cian R; Tavolato M; Galan A
    Retina; 2009; 29(7):949-55. PubMed ID: 19584653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.
    Koh A; Lee WK; Chen LJ; Chen SJ; Hashad Y; Kim H; Lai TY; Pilz S; Ruamviboonsuk P; Tokaji E; Weisberger A; Lim TH
    Retina; 2012 Sep; 32(8):1453-64. PubMed ID: 22426346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.
    Bae SH; Heo J; Kim C; Kim TW; Shin JY; Lee JY; Song SJ; Park TK; Moon SW; Chung H
    Ophthalmology; 2014 Feb; 121(2):558-65. PubMed ID: 24268858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Shiragami C; Shiraga F; Nagayama D; Iida T
    Am J Ophthalmol; 2008 Dec; 146(6):935-41.e1. PubMed ID: 18723139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Shiragami C; Shiraga F; Kano M; Iida T
    Am J Ophthalmol; 2010 Mar; 149(3):472-81.e1. PubMed ID: 20053392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Iida T; Kano M
    Jpn J Ophthalmol; 2013 Mar; 57(2):211-20. PubMed ID: 23208024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised prospective double-masked exploratory study comparing combination photodynamic treatment and intravitreal ranibizumab vs intravitreal ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration.
    Vallance JH; Johnson B; Majid MA; Banerjee S; Mandal K; Bailey CC
    Eye (Lond); 2010 Oct; 24(10):1561-7. PubMed ID: 20577273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization.
    Kang HM; Koh HJ
    Am J Ophthalmol; 2013 Apr; 155(4):713-9, 719.e1. PubMed ID: 23219069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.